Evidence map›Paper›PMID 18230622›Full record

ArticleThe Journal of biological chemistry2008

Isoform-specific inhibition of TRPC4 channel by phosphatidylinositol 4,5-bisphosphate.

Ken-ichi Otsuguro, Jisen Tang, Yufang Tang, Rui Xiao, Marc Freichel, Volodymyr Tsvilovskyy, Shigeo Ito, Veit Flockerzi, Michael X Zhu, Alexander V Zholos

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 170 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Negative self-regulation of transient receptor potential canonical 4 by the specific interaction with phospholipase C-δ1.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Species-Specific Regulation of TRPM2 by PI(4,5)PInternational journal of molecular sciences · 2021
    Article
  13. Article
  14. Review
  15. Nitric oxide resets kisspeptin-excited GnRH neurons via PIP2 replenishment.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  16. TRPC4 as a coincident detector of GCurrent opinion in physiology · 2020
    Article
  17. Article
  18. Article
  19. Review
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Ken-ichi OtsuguroCardiovascular Biomedical Research Centre, School of Medicine and Dentistry, Queen's University Belfast, Belfast, United Kingdom.
Jisen Tang
Yufang Tang
Rui Xiao
Marc Freichel
Volodymyr Tsvilovskyy
Shigeo Ito
Veit Flockerzi
Michael X Zhu
Alexander V Zholos
The Ohio State University · USSaarland University · DEQueen's University Belfast · GBHokkaido University · JP

Funding

Ohio State Neuroscience Centr CoreP30NS045758 · NINDS · OHIO STATE UNIVERSITY · PI OBRIETAN, KARL H · 2004 to 2015
$7.7M
MECHANISM OF CONFORMATIONAL COUPLINGR01NS042183 · NINDS · OHIO STATE UNIVERSITY · PI ZHU, MICHAEL X · 2001 to 2004
$1.1M
High throughput screening of ligands of TRP channelsR21NS056942 · NINDS · OHIO STATE UNIVERSITY · PI ZHU, MICHAEL X · 2006 to 2008
$261k
NINDS NIH HHS P30 NS045758NINDS NIH HHS R01 NS042183NINDS NIH HHS R21 NS056942
6 · The paper itself

Abstract

Full-length transient receptor potential (TRP) cation channel TRPC4alpha and shorter TRPC4beta lacking 84 amino acids in the cytosolic C terminus are expressed in smooth muscle and endothelial cells where they regulate membrane potential and Ca(2+) influx. In common with other "classical" TRPCs, TRPC4 is activated by G(q)/phospholipase C-coupled receptors, but the underlying mechanism remains elusive. Little is also known about any isoform-specific channel regulation. Here we show that TRPC4alpha but not TRPC4beta was strongly inhibited by intracellularly applied phosphatidylinositol 4,5-bisphosphate (PIP(2)). In contrast, several other phosphoinositides (PI), including PI(3,4)P(2), PI(3,5)P(2), and PI(3,4,5)P(3), had no effect or even potentiated TRPC4alpha indicating that PIP(2) inhibits TRPC4alpha in a highly selective manner. We show that PIP(2) binds to the C terminus of TRPC4alpha but not that of TRPC4beta in vitro. Its inhibitory action was dependent on the association of TRPC4alpha with actin cytoskeleton as it was prevented by cytochalasin D treatment or by the deletion of the C-terminal PDZ-binding motif (Thr-Thr-Arg-Leu) that links TRPC4 to F-actin through the sodium-hydrogen exchanger regulatory factor and ezrin. PIP(2) breakdown appears to be a required step in TRPC4alpha channel activation as PIP(2) depletion alone was insufficient for channel opening, which additionally required Ca(2+) and pertussis toxin-sensitive G(i/o) proteins. Thus, TRPC4 channels integrate a variety of G-protein-dependent stimuli, including a PIP(2)/cytoskeleton dependence reminiscent of the TRPC4-like muscarinic agonist-activated cation channels in ileal myocytes.

Indexed as

ActinsAmino Acid MotifsAnimalsCalciumCell LineCytochalasin DCytoskeletonEndothelial CellsGTP-Binding Protein alpha Subunits, Gi-GoGTP-Binding Protein alpha Subunits, Gq-G11HumansIleumMembrane PotentialsMiceMuscle CellsMuscle, SmoothActinsCalciumCytochalasin DGTP-Binding Protein alpha Subunits, Gi-GoGTP-Binding Protein alpha Subunits, Gq-G11Nucleic Acid Synthesis InhibitorsPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol PhosphatesProtein IsoformsTRPC4 ion channelTRPC Cation ChannelsType C Phospholipases

Identifiers

PMID18230622
PMCPMC2365920
OpenAlexW2014670494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.